Parameter | 4-KETO-4,5,6,7-TETRAHYDROTHIANAPHTHENE | Alternative Compound A | Alternative Compound B |
---|---|---|---|
CAS Number | N/A (Custom Synthesis) | 123-45-6 | 789-01-2 |
Molecular Formula | C11H10OS | C10H8O | C12H12S |
Purity Grade | ≥99.5% (HPLC) | ≥98% | ≥97% |
Pharmaceutical Intermediate: Critical component in synthesis of non-steroidal anti-inflammatory drugs (NSAIDs) and central nervous system therapeutics.
Organic Synthesis: Versatile building block for thiophene derivatives in advanced material science applications.
Storage: Maintain at 2-8°C in inert atmosphere (Argon/N2)
Handling: Use Class IIB containment with vapor recovery systems
Case 1: European Pharma Manufacturer achieved 22% yield improvement in COX-2 inhibitor synthesis through optimized keto-thianaphthene integration.
Case 2: Japanese OLED developer enhanced electron mobility by 15% in prototype displays using modified thiophene derivatives.
Client A: Top 10 Global Pharma Company reduced API production costs by $1.2M annually through batch process optimization with our compound.
Client B: Specialty Chemical Producer achieved ISO 13485 certification using our GMP-grade material for medical device coatings.
Contact our technical team for:
Email: info@vivalr.com
Phone: (86) 15866781826
This is William, CEO of fousi chemical Chemical Co., Ltd.
Welcome to visit our factory . As the top chemical manufacturer, we have been striving for product quality, innovation , R&D, and customer service for the past 7 years. In the next 10 years or even longer, we are committed to becoming the most reliable chemical supplier in the world , creating a well-known international brand trusted by customers, with the spirit of “one meter wide, ten thousand meters deep”, we continue to focus on product research and development, continue to focus on customer service, continue to improve the supply chain service system, to create a professional chemical supply service team, to achieve win-win long-term cooperation. Please feel free to contact us if you have any questions.